Author: admin

Continue Reading

  • Emerging Gene Therapies in Sickle Cell Disease: A Comparative Review o

    Emerging Gene Therapies in Sickle Cell Disease: A Comparative Review o

    An Overview of Sickle Cell Disease and Its Treatments

    Sickle cell disease (SCD) is a hereditary haemoglobinopathy resulting from a single point mutation in the β-globin gene (HBB) on chromosome 11, in which adenine is replaced by thymine at…

    Continue Reading

  • President Zardari offers expansion of defence collaboration to Qatari emir – Dawn

    1. President Zardari offers expansion of defence collaboration to Qatari emir  Dawn
    2. Qatar commits to increasing PSX investments  Mettis Global
    3. President Zardari, Emir of Qatar vow to deepen bilateral ties  The Express Tribune
    4. In meeting with Qatari…

    Continue Reading

  • World Tsunami Awareness Day 2025: Investing in preparedness saves lives – ReliefWeb

    1. World Tsunami Awareness Day 2025: Investing in preparedness saves lives  ReliefWeb
    2. The cost of the next wave: Why tsunami risk matters  UNDRR
    3. Waves without mercy  Deccan Herald
    4. From animal behaviour to tide patterns: How traditional knowledge helps…

    Continue Reading

  • What to expect from Apple’s ‘cheap’ MacBook in 2026 (and how it’ll compete with Chromebooks)

    What to expect from Apple’s ‘cheap’ MacBook in 2026 (and how it’ll compete with Chromebooks)

    Kerry Wan/ZDNET

    Follow ZDNET: Add us as a preferred source on Google.

    ZDNET’s key takeaways

    • Apple could be developing a new budget-friendly MacBook for around $599. 
    • It would reportedly house the A18 Pro chipset found in the iPhone 16…

    Continue Reading

  • Fractyl Health to Report Third Quarter 2025 Financial

    Fractyl Health to Report Third Quarter 2025 Financial

    BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D),…

    Continue Reading

  • David Harewood stars in an Othello that thrills but lacks coherence — review

    David Harewood stars in an Othello that thrills but lacks coherence — review

    Unlock the Editor’s Digest for free

    Tom Morris has not made life easy for himself. For the first of a series of Shakespeare productions he is bringing to the…

    Continue Reading

  • Insmed To Present at November and December 2025 Investor Conferences

    Insmed To Present at November and December 2025 Investor Conferences

    BRIDGEWATER, N.J., Nov. 5, 2025 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:

    • Jefferies Global Healthcare Conference in London, on Tuesday, November 18, 2025, at 8:30 a.m. GT / 3:30 a.m. ET.
    • Evercore 8th Annual Healthcare Conference in Coral Gables, Florida, on Tuesday, December 2, 2025, at 11:15 a.m. ET.

    These events will be webcast live and can be accessed by visiting the investor relations section of the Company’s website at www.insmed.com. Webcasts will be archived for a period of 30 days following the conclusion of the live events.

    About Insmed

    Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed’s most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company’s early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

    Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.

    Contact:

    Investors:

    Bryan Dunn
    Vice President, Investor Relations
    (646) 812-4030
    [email protected]

    Media:

    Claire Mulhearn
    Vice President, Corporate Communications
    (862) 842-6819
    [email protected] 

    SOURCE Insmed Incorporated


    Continue Reading

  • DJI’s Osmo Mobile 8 gimbal adds pet tracking and Apple DockKit support

    DJI’s Osmo Mobile 8 gimbal adds pet tracking and Apple DockKit support

    After launching it in China earlier, DJI has unveiled its flagship smartphone gimbal, the Osmo Mobile 8. The new model looks much like the Osmo Mobile 7P and has the same Multifunctional tracking module with a built-in light. However, it adds a…

    Continue Reading